Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
12,074.60
10,984.40
9,839.00
8,748.20
7,604.40
6,209.40
4,130.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,074.60
10,984.40
9,839.00
8,748.20
7,604.40
6,209.40
4,130.27
Raw Material Cost
1,807.10
1,530.50
1,262.20
1,080.30
904.20
736.30
547.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.30
30.60
44.10
54.80
61.50
58.15
58.50
Selling and Distribution Expenses
1,753.10
1,464.30
1,136.60
944.70
840.10
770.46
658.50
Other Expenses
374.04
359.97
311.88
248.55
298.96
177.14
169.60
Total Expenditure (Excl Depreciation)
7,313.90
6,625.10
5,561.70
4,565.30
4,795.40
3,336.29
2,960.80
Operating Profit (PBDIT) excl Other Income
4760.7
4359.3
4277.3
4182.900000000001
2809
2873.1
1169.5
Other Income
455.90
545.50
625.20
321.30
-18.70
156.66
160.74
Operating Profit (PBDIT)
5,423.80
5,110.60
5,083.80
4,652.50
2,915.90
3,139.28
1,437.16
Interest
13.30
30.60
44.10
54.80
61.50
58.15
58.50
Exceptional Items
-560.10
-4,625.70
-478.60
-230.00
1.60
145.18
123.20
Gross Profit (PBDT)
10,267.50
9,453.90
8,576.80
7,667.90
6,700.20
5,473.10
3,582.52
Depreciation
207.20
205.80
181.30
148.30
125.60
109.52
106.94
Profit Before Tax
4,643.20
248.50
4,379.80
4,232.40
2,730.40
3,116.80
1,394.92
Tax
690.00
784.10
760.20
910.40
388.30
405.15
218.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,953.20
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,953.20
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,953.20
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
18,665.80
16,409.60
17,580.40
13,912.70
10,100.00
8,686.82
6,085.24
Earnings per share (EPS)
15.32
-2.08
13.89
12.82
9.01
10.29
4.51
Diluted Earnings per share
15.32
-2.08
13.89
12.82
9.01
10.29
4.51
Operating Profit Margin (Excl OI)
39.43%
39.69%
43.47%
47.81%
36.94%
46.27%
28.31%
Gross Profit Margin
40.17%
4.14%
46.36%
50.08%
37.56%
51.96%
36.36%
PAT Margin
32.74%
-4.88%
36.79%
37.97%
30.8%
43.67%
28.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 9.92% vs 11.64% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 838.09% vs -114.80% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 8.82% vs 2.39% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -56.54% vs -30.61% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Vertex Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
12,074.60
48,194.00
-36,119.40
-74.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,074.60
48,194.00
-36,119.40
-74.95%
Raw Material Cost
1,807.10
16,436.00
-14,628.90
-89.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.30
1,891.00
-1,877.70
-99.30%
Selling and Distribution Expenses
1,753.10
7,149.00
-5,395.90
-75.48%
Other Expenses
374.04
760.10
-386.06
-50.79%
Total Expenditure (Excl Depreciation)
7,313.90
33,077.00
-25,763.10
-77.89%
Operating Profit (PBDIT) excl Other Income
4,760.70
15,117.00
-10,356.30
-68.51%
Other Income
455.90
2,566.00
-2,110.10
-82.23%
Operating Profit (PBDIT)
5,423.80
21,804.00
-16,380.20
-75.12%
Interest
13.30
1,891.00
-1,877.70
-99.30%
Exceptional Items
-560.10
-6,464.00
5,903.90
91.34%
Gross Profit (PBDT)
10,267.50
31,758.00
-21,490.50
-67.67%
Depreciation
207.20
4,121.00
-3,913.80
-94.97%
Profit Before Tax
4,643.20
9,328.00
-4,684.80
-50.22%
Tax
690.00
2,272.00
-1,582.00
-69.63%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,953.20
7,054.00
-3,100.80
-43.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,953.20
7,054.00
-3,100.80
-43.96%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
2.00
-2.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,953.20
7,056.00
-3,102.80
-43.97%
Equity Capital
0
0
0.00
Face Value
0.01
0.10
0.00
Reserves
18,665.80
18,473.00
192.80
1.04%
Earnings per share (EPS)
15.32
3.46
11.86
342.77%
Diluted Earnings per share
15.32
3.46
11.86
342.77%
Operating Profit Margin (Excl OI)
39.43%
31.37%
0.00
8.06%
Gross Profit Margin
40.17%
27.91%
0.00
12.26%
PAT Margin
32.74%
14.64%
0.00
18.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,207.46 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 9.92% vs 11.64% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 395.32 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 838.09% vs -114.80% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 496.79 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 8.82% vs 2.39% in Dec 2024
Annual - Interest
Interest 1.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -56.54% vs -30.61% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.43%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






